Contact
searchSearch
HMP Global
Login

Early Breast Cancer Excellence Forum

Early Breast Cancer
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Nimmi S. Kapoor
Interview
Surgeon-Performed Localization and the Push for Ultrasound Training in Modern Breast Cancer Treatment
06/17/2025
Nimmi S. Kapoor, MD
A guest expert shares how surgeon-performed intraoperative wire localization is improving surgical outcomes in breast cancer care and why ultrasound training must become a core component of breast surgery education.
A guest expert shares how surgeon-performed intraoperative wire localization is improving surgical outcomes in breast cancer care and why ultrasound training must become a core component of breast surgery education.
A guest expert shares how...
06/17/2025
Journal of Clinical Pathways
Fidyk
Videos
Integrating ctDNA Into Early Breast Cancer Pathways: Real-World Findings From Flatiron Health
06/17/2025
Erin Fidyk, MSN, MBA
Flatiron Health’s Erin Fidyk, MSN, MBA, shares findings from a real-world study of early breast cancer showing that ctDNA positivity is consistently linked to worse outcomes across subtypes—highlighting its growing prognostic value and...
Flatiron Health’s Erin Fidyk, MSN, MBA, shares findings from a real-world study of early breast cancer showing that ctDNA positivity is consistently linked to worse outcomes across subtypes—highlighting its growing prognostic value and...
Flatiron Health’s Erin Fidyk,...
06/17/2025
Journal of Clinical Pathways
Ademuyiwa Headshot
Interview
Optimizing Multidisciplinary Care and Novel Therapies in Early Breast Cancer
05/16/2025
In this interview, Foluso Ademuyiwa, MD, MPH, MSCI, discusses the evolving role of ctDNA assays in clinical pathways for early-stage triple-negative breast cancer, the personalization of treatment strategies, the challenges of coordinating...
In this interview, Foluso Ademuyiwa, MD, MPH, MSCI, discusses the evolving role of ctDNA assays in clinical pathways for early-stage triple-negative breast cancer, the personalization of treatment strategies, the challenges of coordinating...
In this interview, Foluso...
05/16/2025
Journal of Clinical Pathways
Adam Brufsky, MD
Interview
The Overall Cost-Effectiveness of Adjuvant Ribociclib in ER+ Early Breast Cancer
04/15/2025
Adam Brufsky, MD, PhD
Adam Brufsky, MD, PhD, discusses how adjuvant ribociclib may offer long-term value in early estrogen-receptor-positive (ER+) breast cancer by reducing costly recurrences, despite its upfront expense.
Adam Brufsky, MD, PhD, discusses how adjuvant ribociclib may offer long-term value in early estrogen-receptor-positive (ER+) breast cancer by reducing costly recurrences, despite its upfront expense.
Adam Brufsky, MD, PhD, discusses...
04/15/2025
Journal of Clinical Pathways
Kalinsky Headshot
Interview
Personalizing Adjuvant Therapy: Insights on Biomarkers, CDK4/6 Inhibitors, and Immunotherapy
03/04/2025
Kevin Kalinsky, MD, MS
In this interview, Kevin Kalinsky, MD, MS, discusses the evolving role of biomarkers, genomic assays, novel therapies, and precision medicine in early breast cancer treatment, highlighting the impact of CDK4/6 inhibitors, immunotherapy,...
In this interview, Kevin Kalinsky, MD, MS, discusses the evolving role of biomarkers, genomic assays, novel therapies, and precision medicine in early breast cancer treatment, highlighting the impact of CDK4/6 inhibitors, immunotherapy,...
In this interview, Kevin...
03/04/2025
Journal of Clinical Pathways
Erika Hamilton
Interview
Pathway Optimization in Early Breast Cancer: Biomarkers, Therapies, and Shared Decision-Making
02/07/2025
Erika P. Hamilton, MD
In this interview, Erika P Hamilton, MD, discusses advancements in clinical pathways for early breast cancer, including the role of genomic assays, emerging therapies such as CDK4/6 inhibitors and immunotherapy, targeted treatments for...
In this interview, Erika P Hamilton, MD, discusses advancements in clinical pathways for early breast cancer, including the role of genomic assays, emerging therapies such as CDK4/6 inhibitors and immunotherapy, targeted treatments for...
In this interview, Erika P...
02/07/2025
Journal of Clinical Pathways
Meisel Headshot
Interview
Improving Early Detection and Treatment for Breast Cancer Patients
01/10/2025
Jane L. Meisel, MD
In this interview, Jane L. Meisel, MD, discusses advancements in early breast cancer detection, the integration of standard and emerging treatments, strategies for improving patient adherence, and opportunities for optimizing care through...
In this interview, Jane L. Meisel, MD, discusses advancements in early breast cancer detection, the integration of standard and emerging treatments, strategies for improving patient adherence, and opportunities for optimizing care through...
In this interview, Jane L....
01/10/2025
Journal of Clinical Pathways
News
Patients With Breast Cancer Experience High Economic Burden and Lower HRQoL: Literature Review
05/15/2024
Grace Taylor, MS, MA
A systematic literature review summarizes the economic and health-related quality of life (HRQoL) outcomes experienced by patients with early-stage hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative...
A systematic literature review summarizes the economic and health-related quality of life (HRQoL) outcomes experienced by patients with early-stage hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative...
A systematic literature review...
05/15/2024
Journal of Clinical Pathways
Dr Andrew Hertler.
Videos
Accelerating Adoption of Hypofractionation in Patients with Early-Stage Breast Cancer
05/19/2023
Andrew Hertler, MD, FACP
Andrew Hertler, MD, Chief Medical Officer, New Century Health, discusses his study on the use of hypofractionation in patients with early-stage breast cancer.
Andrew Hertler, MD, Chief Medical Officer, New Century Health, discusses his study on the use of hypofractionation in patients with early-stage breast cancer.
Andrew Hertler, MD, Chief...
05/19/2023
Journal of Clinical Pathways
JCP Nov-Dec Cover

Current Issue

December 2025
Volume 11
Issue 6
Current Issue
Issue Archive

Special Reports

Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
08/15/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
08/15/2025
Journal of Clinical Pathways
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
08/15/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
08/15/2025
Journal of Clinical Pathways
Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
06/12/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
06/12/2025
Journal of Clinical Pathways
Page 1
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
02/19/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
02/19/2025
Journal of Clinical Pathways
JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use